GIC Private Limited bought 3.66 million shares of HENGRUI PHARMA at an average of HKD 50.5655 per share on August 20, 2026, involving about HKD 185.00 million.
Prior to the acquisition, GIC Private Limited's long position in HENGRUI PHARMA was 36.89 million shares, representing 14.29%; following the acquisition, the holding changed to 40.55 million shares, with the long position ratio rising to 15.7%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.